THE D1 RECEPTOR AND COGNITION AND TRIAL OF A NOVEL D1 AGONIST IN THE SCHIZOPHRENIA SPECTRUM

被引：0
|
作者：
Siever, Larry J. [1 ]
Rosell, Daniel [2 ]
McClure, Margaret [2 ]
Strike, Katherine [3 ]
Barch, Deanna M. [4 ,5 ]
Harvey, Philip [6 ]
Girgis, Ragy [7 ]
Lieberman, Jeffrey [8 ]
Giakoumaki, Stella
Bitsios, Panos
Roussos, Panos [3 ,9 ]
Haroutunian, Vahram [2 ,3 ]
机构：
[1] James J Peters VAMC, Mt Sinai Sch Med, New York, NY USA
[2] James J Peters VAMC, Dept Mental Hlth, New York, NY USA
[3] Mt Sinai Sch Med, Dept Psychiat, New York, NY USA
[4] Washington Univ, Dept Psychol, St Louis, MO 63130 USA
[5] Washington Univ, Dept Psychiat, St Louis, MO USA
[6] Univ Miami, Miller Sch Med, Dept Psychiat & Behav Sci, Miami, FL 33136 USA
[7] Columbia Univ, Dept Mental Hlth Serv, New York, NY USA
[8] Columbia Univ, Dept Psychiat, New York, NY USA
[9] Univ Crete, Dept Psychiat & Behav Sci, Iraklion, Greece
来源：
SCHIZOPHRENIA RESEARCH | 2014年 / 153卷
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：S5 / S6
页数：2
相关论文
共 50 条
  • [1] D1 receptor binding and agonist effects on cognitive function in the schizophrenia spectrum
    Siever, LJ
    BIOLOGICAL PSYCHIATRY, 2005, 57 (08) : 84S - 85S
  • [2] Psychopathology and D1 Receptor Availability in Schizophrenia
    Eisenberg, Daniel
    Kohn, Philip
    Gregory, Michael
    Hamborg, Madeline
    Czarapata, Jasmin
    Berman, Karen
    NEUROPSYCHOPHARMACOLOGY, 2021, 46 (SUPPL 1) : 332 - 332
  • [3] Application of D1 receptor antagonist prevents learning enhancement induced by D1 receptor agonist in the ventral pallidum
    Olah-Varady, K.
    Peczely, L.
    Laszlo, K.
    Kertes, E.
    Berta, B.
    Lenard, L.
    ACTA PHYSIOLOGICA HUNGARICA, 2007, 94 (04) : 382 - 382
  • [4] Dopamine Release and D1 Binding in the Schizophrenia Spectrum
    Siever, Larry J.
    Thompson, Judy
    Slifstein, Mark
    Iskander, Elisabeth
    Abi-Dargham, Anissa
    BIOLOGICAL PSYCHIATRY, 2010, 67 (09) : 97S - 97S
  • [5] Investigation of D1 Receptor-Agonist Interactions and D1/D2 Agonist Selectivity Using a Combination of Pharmacophore and Receptor Homology Modeling
    Malo, Marcus
    Brive, Lars
    Luthman, Kristina
    Svensson, Peder
    CHEMMEDCHEM, 2012, 7 (03) : 483 - 494
  • [6] A D1/D2 CHIMERIC DOPAMINE RECEPTOR MEDIATES A D1 RESPONSE TO A D2-SELECTIVE AGONIST
    MACKENZIE, RG
    STEFFEY, ME
    MANELLI, AM
    POLLOCK, NJ
    FRAIL, DE
    FEBS LETTERS, 1993, 323 (1-2) : 59 - 62
  • [7] SCHIZOPHRENIA AND THE D1 RECEPTOR - FOCUS ON NEGATIVE SYMPTOMS
    LYNCH, MR
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 1992, 16 (06): : 797 - 832
  • [8] The novel d1 selective opioid receptor agonist SB235863A preconditions the isolated rat heart independently from d1 receptor activation
    Rovekamp, B
    Minners, J
    Sack, M
    Opie, LH
    EUROPEAN HEART JOURNAL, 2000, 21 : 42 - 42
  • [9] Dihydrexidine -: The first full dopamine D1 receptor agonist
    Salmi, P
    Isacson, R
    Kull, B
    CNS DRUG REVIEWS, 2004, 10 (03): : 230 - 242
  • [10] The selective dopamine D1 receptor agonist SKF81297 modulates NMDA receptor currents independently of D1 receptors
    Nesbit, Maya O.
    Chai, Anping
    Axerio-Cilies, Peter
    Phillips, Anthony G.
    Wang, Yu Tian
    Held, Katharina
    NEUROPHARMACOLOGY, 2022, 207
12345